- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 151.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 150.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 139.93M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $94.16K |
| Capex | Q1 2026 · Mar 31, 2025 | $17.95K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$307.46K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$971.83K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $3.66M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.95M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $1.01M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $1.04M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $571.22K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $528.72K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$21.92M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$20.28M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $56.41M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $55.29M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $64.66M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $63.31M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $23.95M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $25.51M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $100.76M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $103.15M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.03M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.13M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.25M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$943.67K |
| Revenue | Q1 2026 · Mar 31, 2026 | $6.3M |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |